Article
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2007
Jamieson David, Wilson Kerrie, Pridgeon Simon, Margetts Jane P, Edmondson Richard J, Leung Hing Y, Knox Richard, Boddy Alan V
Abstract excerpt
PURPOSE: NRH:quinone oxidoreductase 2 (NQO2) is a homologue of NAD(P)H:quinone oxidoreductase 1 (NQO1). Despite 54% homology with human NQO1, NQO2 has little endogenous enzymatic activity. However, NQO2 has potential as a therapeutic target because the addition of the nonbiogenic electron donor dihydronicotinamide riboside (NRH) selectively potentiates the bioactivation of the alkylating agent tretazicar (CB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
